ODILIA HOLDINGS, LLC – Trademark Portfolio
Entity Type: 16
ODILIA HOLDINGS, LLC has 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include ALPHALAND. The portfolio includes 2 registered trademarks. Filings span 5 Nice Classification classes, led by Class 36 (Insurance & Financial) and Class 5 (Pharmaceuticals). This trademark owner is based in SUGAR LAND, TX.
4659 WRIGHT RD
SUGAR LAND, TX 77477
Showing of trademarks Trademarks
Trademark Classifications
ODILIA HOLDINGS, LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does ODILIA HOLDINGS, LLC have?
ODILIA HOLDINGS, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 abandoned.
What trademark classes does ODILIA HOLDINGS, LLC file in?
ODILIA HOLDINGS, LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 41 (Education & Entertainment), Class 32 (Light Beverages). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are ODILIA HOLDINGS, LLC's most well-known trademarks?
ODILIA HOLDINGS, LLC's registered trademark portfolio includes well-known marks such as ALPHALAND. These are among 2 currently registered trademarks in the portfolio.
What is ODILIA HOLDINGS, LLC's trademark registration success rate?
ODILIA HOLDINGS, LLC has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.